Skip to main content
Abstract
Originally Published 1 May 1994
Free Access

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Abstract

The compositions of lesion types that precede and that may initiate the development of advanced atherosclerotic lesions are described and the possible mechanisms of their development are reviewed. While advanced lesions involve disorganization of the intima and deformity of the artery, such changes are absent or minimal in their precursors. Advanced lesions are either overtly clinical or they predispose to the complications that cause ischemic episodes; precursors are silent and do not lead directly to complications. The precursors are arranged in a temporal sequence of three characteristic lesion types. Types I and II are generally the only lesion types found in children, although they may also occur in adults. Type I lesions represent the very initial changes and are recognized as an increase in the number of intimal macrophages and the appearance of macrophages filled with lipid droplets (foam cells). Type II lesions include the fatty streak lesion, the first grossly visible lesion, and are characterized by layers of macrophage foam cells and lipid droplets within intimal smooth muscle cells and minimal coarse-grained particles and heterogeneous droplets of extracellular lipid. Type III (intermediate) lesions are the morphological and chemical bridge between type II and advanced lesions. Type III lesions appear in some adaptive intimal thickenings (progression-prone locations) in young adults and are characterized by pools of extracellular lipid in addition to all the components of type II lesions.

Formats available

You can view the full content in the following formats:

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Information & Authors

Information

Published In

Go to Circulation
Go to Circulation
Circulation
Pages: 2462 - 2478
PubMed: 8181179

History

Published online: 1 May 1994
Published in print: May 1994

Permissions

Request permissions for this article.

Authors

Affiliations

H C Stary
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
A B Chandler
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
S Glagov
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
J R Guyton
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
W Insull, Jr
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
M E Rosenfeld
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
S A Schaffer
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
C J Schwartz
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
W D Wagner
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
R W Wissler
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Roles of Hydrogen Sulfide (H2S) as a Potential Therapeutic Agent in Cardiovascular Diseases: A Narrative Review, Cureus, (2024).https://doi.org/10.7759/cureus.64913
    Crossref
  2. Potential Benefits and Risks Associated with the Use of Statins, Pharmaceutics, 16, 2, (214), (2024).https://doi.org/10.3390/pharmaceutics16020214
    Crossref
  3. Comment on Bažadona et al. The Interconnection between Carotid Intima–Media Thickness and Obesity: Anthropometric, Clinical and Biochemical Correlations. Medicina 2023, 59, 1512, Medicina, 60, 6, (981), (2024).https://doi.org/10.3390/medicina60060981
    Crossref
  4. Myocardial Perfusion Imaging and C-Reactive Protein in Myocardial Ischemia: A Retrospective Single-Center Study, Life, 14, 2, (261), (2024).https://doi.org/10.3390/life14020261
    Crossref
  5. Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge, Biomedicines, 12, 7, (1608), (2024).https://doi.org/10.3390/biomedicines12071608
    Crossref
  6. Determinants of Risk Factors Associated with Aortic Atherosclerosis: A Quantitative Study in Forensic Autopsies, Biosciences Biotechnology Research Asia, 21, 1, (157-162), (2024).https://doi.org/10.13005/bbra/3211
    Crossref
  7. Pathogenesis of human atheroma necrotic core: degradation of connective tissue fibers and possible involvement of cathepsin K, Translational Medicine Communications, 9, 1, (2024).https://doi.org/10.1186/s41231-024-00188-6
    Crossref
  8. Exogenous Growth Hormone Exacerbates Post-Irradiation Atherosclerosis in Susceptible Epicardial Coronary Arteries, Toxicologic Pathology, (2024).https://doi.org/10.1177/01926233241277454
    Crossref
  9. Effects of Different Eccentric Cycling Intensities on Brachial Artery Endothelial Shear Stress and Blood Flow Patterns, Research Quarterly for Exercise and Sport, (1-11), (2024).https://doi.org/10.1080/02701367.2024.2404139
    Crossref
  10. The amelioration of a purified Pleurotus abieticola polysaccharide on atherosclerosis in ApoE −/− mice , Food & Function, 15, 1, (79-95), (2024).https://doi.org/10.1039/D3FO02740F
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
Circulation
  • Vol. 89
  • No. 5

Purchase access to this journal for 24 hours

Circulation
  • Vol. 89
  • No. 5
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response